Absorption, metabolism and excretion of [¹⁴C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans

By Kim Namtae   Patrick Lorna   Mair Stuart   Stevens Lloyd   Ford Gill   Birks Vicky   Lee Sung-Hack  

Xenobiotica, Vol. 44, Iss. 6, 2014-06 ,pp. : 522-530

Informa Healthcare

Access to resources Recommend Favorite

Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog

By Naitoh T.   Mishima M.   Kawaguchi S.   Matsui K.   Andoh T.   Kagei K.   Kakiki M.   Yuzuriha T.   Horie T.  

Xenobiotica, Vol. 27, Iss. 10, 1997-10 ,pp. : 1053-1070

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of BAY 59-7939 – an oral, direct Factor Xa inhibitor – in rats and dogs

By Weinz C.   Buetehorn U.   Daehler H.-P.   Kohlsdorfer C.   Pleiss U.   Sandmann S.   Schlemmer K.-H.   Schwarz T.   Steinke W.  

Xenobiotica, Vol. 35, Iss. 9, 2005-09 ,pp. : 891-910

Informa Healthcare

Access to resources Recommend Favorite

Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans

By Bruderer Shirin   Hopfgartner Gérard   Seiberling Michael   Wank Janine   Sidharta Patricia N.   Treiber Alexander   Dingemanse Jasper  

Xenobiotica, Vol. 42, Iss. 9, 2012-09 ,pp. : 901-910

Informa Healthcare

Access to resources Recommend Favorite

Metabolism and urinary excretion of a new quinoline anticancer drug, TAS-103, in humans

By Azuma R.   Saeki M.   Yamamoto Y.   Hagiwara Y.   Grochow L. B.   Donehower R. C.  

Xenobiotica, Vol. 32, Iss. 1, 2002-01 ,pp. : 63-72

Informa Healthcare

Access to resources Recommend Favorite